Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × Vemurafenib × Clear all

Phase

Phase 2 9 Phase 1 2 Phase 3 1 Phase 2/3 1

Status

Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 13 Paclitaxel 11 Cyclophosphamide 10 Doxorubicin 9 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Docetaxel 8 Carboplatin 8 Prednisone 7 Oxaliplatin 7 pembrolizumab 6 Specimen Handling 6 Etoposide 6 Capecitabine 6 Vincristine 5 Radiotherapy 5 Leucovorin 5 Bevacizumab 5 atezolizumab 4 Trastuzumab 4 Platinum 4 Nivolumab 4 Fluorouracil 4 Cytarabine 4 Biopsy 4 1,2-diaminocyclohexaneplatinum II citrate 4 Watchful Waiting 3 Taxes 3 Rituximab 3 Ramucirumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03178552 2026-03-09

B-FAST

Hoffmann-La Roche

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡